共 50 条
- [41] TORS for head and neck squamous cell carcinoma (HNSCC): the Hamburg experience B-ENT, 2015, 11 : 33 - 36
- [46] A Phase II Trial of Personalized Immunotherapy in Patients (pts) with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M HNSCC) That Have Progressed on Prior Immunotherapy INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E4 - E4
- [48] Immune Landscape and Role of Immunotherapy in Treatment of HPV-Associated Head and Neck Squamous Cell Carcinoma (HNSCC) Current Otorhinolaryngology Reports, 2022, 10 : 96 - 107